跳至主要内容
临床试验/NCT01464515
NCT01464515Unknown1 期

Feasibility Study in Order to Test the Efficiency of Deep TMS on Patient With MCI

Brainsway1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年1月最近更新:
适应症

试验速览

阶段
1 期
发起方
Brainsway
入组人数
30
试验地点
1
主要终点
Mindstreams

研究概览

简要总结

This is a first feasibility study in order to test if deep Transcranial Magnetic Stimulation (TMS) treatment with high frequency (10Hz) will improve the symptoms of patient MCI (Mild Cognitive impairment). The hypothesis of the study is that high frequency treatment with deep TMS will improve the daily functioning of patients who suffers from MCI.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
55 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women 50-80 years of age.
  • Self reporting of the patient about memory deterioration, without any damage of daily lify functioning.
  • Scored of one standard deviation below the average (according to standardization of age and years of schooling) in the memory index and Mindstream test, without any major damage of other cognitive function)
  • score >= 24 in MMSE (Mini Mental State Examination) test.
  • Preserved Cognitive and executive functioning, without dementia according to DSM -IV
  • Lack of other reason for memory deterioration like acute affect disorder or other neurological disorders, according to the doctor diagnosis.
  • Score of maximum 0.5 in the Clinical Dementia Rating. in this test the score of the memory index will be 0.5 or 1, and not more then 1 point in two other index of this test.
  • Capable and willing to provide informed consent.

排除标准

  • Any other Axis I diagnosis as the primary diagnosis
  • Any medications that can cause a risk of seizure. for instance, anti psychotic medication, high dosage of anti depression medication
  • History of non tolerance for TMS treatment
  • Diagnosis of Severe personality disorder according to DSM-IV
  • current suicidal tendency
  • Uncontrolled hypertension
  • History of epilepsy, seizure, or heat convulsion
  • History of epilepsy or seizure in first degree relatives
  • History of head injury or stroke
  • History of metal implants in the head (except dental fillings)
  • History of surgery entailing metallic implants or known history of any metallic particles in the eye, implanted cardiac pacemaker, cochlear implants, use of neurostimulators, or any medical pumps
  • History of drug or alcohol abuse
  • Inadequate communication with examiner
  • Participation in another clinical study, either concurrent with this trial or in the 3 months preceding it
  • Inability to sign a consent form
  • Women of childbearing potential and not using a medically accepted form of contraception when engaging in sexual intercourse

结局指标

主要结局

Mindstreams

时间窗: the test will be assessed on visit 17 which means 4 month from baseline

Mindstreams test is designed to test the I.Q change of the patients from baseline

次要结局

  • CDR - Clinical Dementia Rating(the test will be assessed on visit 17 which means 4 month from baseline)

研究者

发起方
Brainsway
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验